| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |